Drug Profile
ES 8891
Alternative Names: RS 8891Latest Information Update: 24 Jan 2017
Price :
$50
*
At a glance
- Originator Sankyo
- Class Antihypertensives
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 23 Jan 2017 Discontinued - Phase-I for Hypertension in Japan (PO)
- 19 Oct 2000 Suspended-I for Hypertension in Japan (PO)